InMed Pharmaceuticals Inc. Common Shares (INM) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on InMed Pharmaceuticals Inc. Common Shares (INM) is Moderate Underperform.

The composite score behind that read is -0.36, weighing +0.00 of bullish evidence against -0.61 bearish.

InMed Pharmaceuticals Inc. Common Shares last closed at $1.36, +2.26% on the session.

Against the IVW growth benchmark the position is +1.46% over the forecast window.

The read is built from 15 underlying insights — 0 bullish and 15 bearish.

Agreement across those insights is 100%.

20 graded predictions for INM so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

InMed Pharmaceuticals Inc. Common Shares is classified under Health Care / Pharmaceuticals, with a market capitalisation of $7.31M.

StockMap tracks InMed Pharmaceuticals Inc. Common Shares as the 133rd largest of the 151 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 90 Neutral, 46 Moderate Underperform and 15 Moderate Outperform.

On that composite InMed Pharmaceuticals Inc. Common Shares ranks 140th of 151 in the group, against a group median of -0.08.